Friday, 22 October 2021 12:27 GMT

Teleflex Announces Third Quarter 2021 Earnings Conference Call Information

(MENAFN- GlobeNewsWire - Nasdaq) WAYNE, Pa., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, October 28, 2021.

To register for the conference call and receive dial-in information, please use the following link: . The call can also be accessed through a live audio webcast on the company's website .

An audio replay of the call will be available beginning at 11:00 am Eastern Time on October 28, 2021 either on the Teleflex website or by telephone. The call can be accessed by dialing 800-585-8367 (U.S./Canada) or 416-621-4642 (International). The confirmation code is 4079822.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit .

Teleflex is the home of Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.

Teleflex Incorporated:
Lawrence Keusch
Vice President, Investor Relations and Strategy Development

John Hsu, CFA
Vice President, Investor Relations

Tags Teleflex Medical Devices Healthcare


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.